Evaluation of Patients With Gastrointestinal Disease

Status Recruiting

Clinical Trial Summary

Background: Ongoing and future research projects that study gastrointestinal diseases depend on access to biological samples and clinical data. Researchers want to study people who are seen and treated for these diseases. This may help them assess and treat these diseases better in the future. Objective: To collect data and samples from people being seen and/or treated for gastrointestinal problems at NIH, to use in future research. Eligibility: Adults aged 18 and older who have known or suspected gastrointestinal disorders or need screening, treatment, or follow-up per current medical guidelines. Design: Participants will be screened with a physical exam. Their medical records will be reviewed. Participants will be seen by doctors based on the ailment they have. Their condition will be treated just like it would at a doctor s office. But the data and samples collected will be used for future research. Participants may give blood, urine, and/or stool samples. If participants have an endoscopy or colonoscopy as part of their standard care and samples are taken, they may be asked to give their leftover samples to NIH. Or, they may be asked to have extra samples taken for NIH to use. These samples may include gastric acid and/or tissue from the lining of the stomach or intestines. If samples are not taken as part of their standard care, they may be asked to have samples taken for NIH to use. Data will be stored at NIH. The data systems are password protected. Samples will be coded. Participants will take part in the study for as long as they agree to be seen for their disease....

Clinical Trial Description

Patients with suspected or established acute or chronic gastrointestinal diseases or who require clinical screening for gastrointestinal diseases are provided standard clinical care for their condition. Data and samples obtained during regular clinical care will be retained for future research in gastrointestinal diseases. Recommendations for other treatment options outside of the NIH will be discussed with study patients and may be discussed with their primary or referring physicians. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05041374
Study type	Observational
Source	National Institutes of Health Clinical Center (CC)
Contact	Beverly E Niles
Phone	(301) 451-0659
Email	beverly.niles@nih.gov
Status	Recruiting
Phase
Start date	January 4, 2022
Completion date	December 31, 2035

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02541357` - Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery	N/A
Active, not recruiting	`NCT02358122` - Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh	N/A
Active, not recruiting	`NCT02442115` - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Enrolling by invitation	`NCT00943345` - Validation of New Tests for Gastrointestinal (GI) Permeability	Phase 0
Completed	`NCT00612404` - Symptoms and Endoscopic Results in Consideration of Pretreatment	N/A
Completed	`NCT01127711` - Cohort of Swedish Men	N/A
Recruiting	`NCT05712525` - Gut Recovery In Patients Following Surgery
Recruiting	`NCT06094153` - Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function	N/A
Recruiting	`NCT05322486` - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Completed	`NCT02486146` - GI Biorepository of Tissue and Bodily Fluids	N/A
Completed	`NCT01816607` - Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Completed	`NCT00247715` - Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)	N/A
Completed	`NCT00035334` - Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis	Phase 2/Phase 3
Recruiting	`NCT06286865` - Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial	N/A
Active, not recruiting	`NCT01037049` - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks	Phase 2
Completed	`NCT03725813` - Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit	N/A
Recruiting	`NCT05640401` - Holographic Screens as a Replacement of Monitors During GI Endoscopies	N/A
Completed	`NCT02865564` - Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics	N/A
Completed	`NCT02651857` - Exploratory Study of Upper and Lower Endoscopic Fuse System	N/A
Active, not recruiting	`NCT01984034` - Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.